This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Fouillard, L Articles by Miossec, P Search for Related Content PubMed PubMed Citation Articles by Fouillard, L Articles by Miossec, P Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB CYCLOPHOSPHAMIDE Medline Plus Health Information Lupus Social Bookmarking                         What's this?

Control of severe systemic lupus erythematosus after high-dose immunusuppressive therapy and transplantation of CD34+ purified autologous stem cells from peripheral blood

N C Gorin

J Ph Laporte

A Leon

Department of Hematology, Hôpital Saint-Antoine, and Centre de Recherches Claude-Bernard sur la Thérapie Cellulaire, Paris, France

J F Brantus

P Miossec

Clinical Immunology Unit, Dept of Rheumatology, Hoôpital Edouard Herriot, Lyon, France

A 35 y old woman with severe and progressive systemic lupus erythematosus (SLE) received highdose chemotherapy followed by a T cell depleted autologous stem cell transplantation. Peripheral blood stem cell were mobilised with Cyclophosphamide 4.5 g/m² followed by Granulocyte-Colony Stimulating Factor (G-CSF). A CD34 positive selection provided a 3 log T cell depletion. High-dose immunosuppression consisted of the BEAM regimen. The purified autograft was reinfused on day 0. In the post transplant period, hemopoietic growth factors, G-CSF, Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Erythropoietin, were administered, engraftment was rapid. Both the mobilisation and the transplant procedures were easily performed and well tolerated. One year later, the patient is in clinical remission. The ANA and anti-SSA-antibodies were undetectable at 1 and 6 months after intensification, but reappeared at low levels at 9 months. Corticosteroid requirement has gradually decreased. In conclusion, we report here the favourable evolution of a patient with a severe SLE, who clinically improved with high-dose immunosuppressive therapy and autologous stem cell transplantation, and showed a 9 month serological remission.

Key Words: severe systemic lupus erythematosus • autologous stem cell transplantation

Lupus, Vol. 8, No. 4, 320-323 (1999)
DOI: 10.1191/096120399678847894


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				L. Statkute, A. Traynor, Y. Oyama, K. Yaung, L. Verda, N. Krosnjar, and R. K. Burt Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation Blood, October 15, 2005; 106(8): 2700 - 2709. [Abstract] [Full Text] [PDF]

				D Jayne and A Tyndall Autologous stem cell transplantation for systemic lupus erythematosus Lupus, May 1, 2004; 13(5): 359 - 365. [Abstract] [PDF]

				D. Jayne, J. Passweg, A. Marmont, D. Farge, X. Zhao, R. Arnold, F. Hiepe, I. Lisukov, M. Musso, J. Ou-Yang, et al. Autologous stem cell transplantation for systemic lupus erythematosus Lupus, March 1, 2004; 13(3): 168 - 176. [Abstract] [PDF]

				R. K. Burt, S. Slavin, W. H. Burns, and A. M. Marmont Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure? Blood, February 1, 2002; 99(3): 768 - 784. [Abstract] [Full Text] [PDF]

				A M Marmont Lupus: tinkering with haematopoietic stem cells Lupus, November 1, 2001; 10(11): 769 - 774. [PDF]

				A M Marmont Intense immunosuppression and stem cell transplantation or rescue for severe systemic lupus erythematosus Lupus, May 1, 1999; 8(4): 256 - 257. [PDF]